GPP Documents and Resources
GPP
Guidelines
The Good Participatory Practice Guidelines for Biomedical HIV Prevention Trials (GPP) are guidelines for trial implementers and sponsors that describe how they should effectively engage with communities when conducting biomedical HIV prevention trials. The guidelines identify core principles, essential issues, and minimum elements of how stakeholders should plan, conduct, and evaluate community engagement in biomedical HIV prevention trials. The GPP Guidelines were published by UNAIDS and AVAC in November, 2007.
Take a look at the Guidelines, which are available in seven languages:
GPP Facilitator's Guide
To help make the full GPP guidelines easier to understand and accessible to a wider range of stakeholders, AVAC has developed a Facilitator's Guide for community use. The Facilitator's Guide is a companion to the full GPP guidelines and provides a summary of the guidelines, discussion tools, and case studies.
GPP Summary Document
The GPP Summary Document highlights the main points of the GPP guidelines. (English coming soon.)
Guidelines and documents related to GPP
Ethical Considerations in Biomedical HIV Prevention Trials
(WHO/UNAIDS - 2007)
Ethics Issues for Canadian HIV/AIDS Researchers in International Settings (Canadian Association for HIV/AIDS Research - 2008)
Recommendations for Community Involvement in National Institute of Allergy and Infectious Diseases HIV/AIDS Clinical Trials Research (the HIV/AIDS Network Coordination project - 2009)
(English full doc) (Spanish executive summary)
HIV Prevention Trials Network: Ethics Guidance for Research, 10 June 2009
HPTN Ethics Guidance webpage
The Good Participatory Practice Guidelines for Biomedical HIV Prevention Trials (GPP) are guidelines for trial implementers and sponsors that describe how they should effectively engage with communities when conducting biomedical HIV prevention trials. The guidelines identify core principles, essential issues, and minimum elements of how stakeholders should plan, conduct, and evaluate community engagement in biomedical HIV prevention trials. The GPP Guidelines were published by UNAIDS and AVAC in November, 2007.
Take a look at the Guidelines, which are available in seven languages:
GPP Facilitator's Guide
To help make the full GPP guidelines easier to understand and accessible to a wider range of stakeholders, AVAC has developed a Facilitator's Guide for community use. The Facilitator's Guide is a companion to the full GPP guidelines and provides a summary of the guidelines, discussion tools, and case studies.
- English - A4 size formatting
- English - 8.5" x 11" size
formatting
- Español
- Français
- isiZulu
- Kiswahili
- Português
- Sesotho
- 中文
- الْعَرَبيّة
- русский
- ภาษาไทย
GPP Summary Document
The GPP Summary Document highlights the main points of the GPP guidelines. (English coming soon.)
Guidelines and documents related to GPP
Ethical Considerations in Biomedical HIV Prevention Trials
(WHO/UNAIDS - 2007)
Ethics Issues for Canadian HIV/AIDS Researchers in International Settings (Canadian Association for HIV/AIDS Research - 2008)
Recommendations for Community Involvement in National Institute of Allergy and Infectious Diseases HIV/AIDS Clinical Trials Research (the HIV/AIDS Network Coordination project - 2009)
(English full doc) (Spanish executive summary)
HIV Prevention Trials Network: Ethics Guidance for Research, 10 June 2009
HPTN Ethics Guidance webpage